| Megan Klausmeyer, PHARMD | |
|
2003 E 1st St, Pratt, KS 67124-8460 | |
| (620) 672-7525 | |
| (620) 672-2673 |
| Full Name | Megan Klausmeyer |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2003 E 1st St, Pratt, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205243169 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-14363 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Klausmeyer, PHARMD 2003 E 1st St, Pratt, KS 67124-8460 Ph: (620) 672-5584 | Megan Klausmeyer, PHARMD 2003 E 1st St, Pratt, KS 67124-8460 Ph: (620) 672-7525 |
News Archive
The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.
HHS Secretary Kathleen Sebelius today called on states and communities to join with HHS to redouble efforts to find and enroll the 5 million children who are currently eligible for Medicaid or the Children's Health Insurance Program (CHIP), but are not yet covered. The Secretary issued this call to action as she opened the National Children's Health Insurance Summit in Chicago, kicking off the nation's largest campaign to find and enroll uninsured children in over a decade.
A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today.
Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ultimately provide a new diagnostic or therapeutic target to detect cancer early or stop tumor growth.
A research review led by Oxford Brookes University has found a large proportion of COVID-19 survivors will be affected by neuropsychiatric and cognitive complications.
› Verified 2 days ago
Mr. Terry Lynn Gatlin, BSPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 E 1st St, Pratt, KS 67124 Phone: 620-672-5584 Fax: 620-672-0508 | |
Jorden P Hirt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 E 1st St, Pratt, KS 67124 Phone: 620-672-5584 Fax: 620-672-0508 | |
Brittney Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 420 Country Club Rd, Pratt, KS 67124 Phone: 620-672-7447 | |
Janet Marie Finger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 E 1st St, Pratt, KS 67124 Phone: 620-672-5584 Fax: 620-672-0508 | |
Staci Snider, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1106 Maple St, Pratt, KS 67124 Phone: 620-388-0787 | |
Mallory Wang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 E 1st St, Pratt, KS 67124 Phone: 620-672-5584 |